AK139 for asthma: a new injection study
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational drug called AK139, given as an injection, to see if it can improve asthma control. It may be an option for people who have had asthma for at least a year and still have symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had asthma for at least one year.
- Your asthma symptoms are not well controlled (based on a standard questionnaire).
- Your breathing test (called FEV1) shows that airflow improves after using a rescue inhaler.
- You are willing to use effective birth control during the study and for 3 months after the last treatment.
- You do not have other lung conditions that could interfere with the study.
- You have not had a severe asthma flare-up in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called SHR-1905 for people with severe asthma that is not well controlled by their current treatments. The study aims to see if the drug can reduce asthma attacks and improve breathing.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.